Compare Agilent Technologies Inc (A) vs Coupang Inc (CPNG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Coupang Inc — how do they compare? Agilent Technologies Inc trades at $128.89 (market cap $37.04B), while Coupang Inc trades at $18.73 (market cap $33.26B). The key difference: Agilent Technologies Inc and Coupang Inc are close in size by market cap, and Agilent Technologies Inc pays a 0.78% dividend while Coupang Inc pays none. Which is the better fit depends on your goals.
| A | CPNG | |
|---|---|---|
Market Cap | $37.04B | $33.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $33.53 |
52-Week Low | $110.24 | $15.12 |
Enterprise Value | $38.59B | $32.36B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Coupang (CPNG) trades at $18.53, showing minimal daily movement (-0.16%) amid mixed technical signals. The stock maintains bullish moving averages but faces resistance near $20. Fundamentally, revenue growth remains strong at $34.53B (2025) though profitability is inconsistent with recent quarterly EPS misses. Regulatory challenges emerged with a $409 million data breach fine in June 2026, though investor sentiment improved as the penalty was below worst-case fears.
Wall Street maintains strong bullish consensus (87.5% buy ratings) with a $25.80 price target implying 39% upside. Key opportunities include sustained e-commerce growth and operational cash flow strength ($1.77B in 2025), while risks center on regulatory scrutiny, competitive pressures, and volatile profitability. The stock's high P/E (184.18) requires continued execution to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Coupang Inc
Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →
